Piramal Pharma Limited (BOM:543635)

Piramal Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	5,686	12,236	3,889	3,714	1,956	2,281
Short-Term Investments	2,614	-	-	-	1	7.1
Trading Asset Securities	-	1,318	195.6	1,447	4,271	504
Cash & Short-Term Investments	8,300	13,554	4,085	5,160	6,228	2,792
Cash Growth	11.55%	231.80%	-20.84%	-17.14%	123.06%	-28.00%
Accounts Receivable	22,537	22,105	23,757	21,348	18,144	18,086
Other Receivables	-	433.4	453.7	171.3	35.6	141.9
Receivables	22,537	22,539	24,211	21,519	18,179	18,228
Inventory	32,948	30,644	23,127	21,759	16,814	13,888
Prepaid Expenses	-	977.4	791.8	640.2	765.7	695.5
Restricted Cash	-	-	1,125	1,112	1,021	913.5
Other Current Assets	8,751	4,202	4,630	4,454	5,347	4,155
Total Current Assets	72,537	71,917	57,970	54,645	48,355	40,672
Property, Plant & Equipment	58,894	56,419	50,235	48,160	44,415	37,157
Long-Term Investments	1,722	2,442	2,268	2,403	2,119	2,168
Goodwill	14,053	12,574	11,482	11,226	11,075	10,305
Other Intangible Assets	31,538	28,845	29,386	31,672	33,382	33,053
Long-Term Accounts Receivable	-	-	-	-	18.6	750.6
Long-Term Deferred Tax Assets	4,940	5,147	3,931	3,865	3,493	2,973
Other Long-Term Assets	1,689	2,307	1,504	1,149	2,369	892
Total Assets	185,372	179,650	156,776	153,118	145,226	127,970

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	27,348	24,791	15,338	15,384	11,927	10,264
Accrued Expenses	489.7	2,574	2,991	2,448	2,642	2,141
Short-Term Debt	-	7,478	9,953	11,714	13,023	6,588
Current Portion of Long-Term Debt	12,117	4,477	5,109	9,037	8,189	7,424
Current Portion of Leases	475.4	436.8	370.4	333.1	303.9	184.4
Current Income Taxes Payable	74.3	105.5	96.1	403	35.4	716.6
Current Unearned Revenue	-	42.3	45	19.6	859	452.7
Other Current Liabilities	11,080	7,678	3,760	4,355	1,451	2,564
Total Current Liabilities	51,585	47,583	37,663	43,693	38,431	30,333
Long-Term Debt	44,536	43,000	32,141	24,838	33,835	26,221
Long-Term Leases	1,600	1,728	991.6	1,180	1,019	862
Long-Term Unearned Revenue	-	300.2	295.1	238	335.6	460.3
Pension & Post-Retirement Benefits	-	569.2	486.6	322.3	205.9	125.1
Long-Term Deferred Tax Liabilities	3,511	3,582	2,484	2,292	2,193	1,920
Other Long-Term Liabilities	2,493	1,262	1,461	1,442	1,471	1,082
Total Liabilities	103,725	98,024	75,521	74,004	77,491	61,004

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	13,284	13,272	13,244	13,230	11,933	11,859
Additional Paid-In Capital	-	47,683	47,372	47,249	38,187	37,252
Retained Earnings	-	6,919	10,493	9,707	9,564	11,589
Comprehensive Income & Other	68,139	13,752	10,146	8,928	8,050	6,267
Shareholders' Equity	81,647	81,626	81,255	79,114	67,735	66,966
Total Liabilities & Equity	185,372	179,650	156,776	153,118	145,226	127,970

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	58,729	57,120	48,565	47,102	56,371	41,279
Net Cash (Debt)	-50,428	-43,566	-44,480	-41,941	-50,143	-38,487
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-37.93	-32.87	-33.43	-32.68	-42.13	-32.65
Filing Date Shares Outstanding	1,395	1,327	1,324	1,323	1,193	1,186
Total Common Shares Outstanding	1,395	1,327	1,324	1,323	1,193	1,186
Working Capital	20,951	24,334	20,307	10,952	9,924	10,339
Book Value Per Share	58.37	61.50	61.35	59.80	56.76	56.47
Tangible Book Value	35,832	40,207	40,386	36,216	23,278	23,608
Tangible Book Value Per Share	25.69	30.30	30.50	27.38	19.51	19.91
Land	-	2,002	1,792	1,729	1,339	1,300
Buildings	-	22,426	20,380	18,949	15,260	11,996
Machinery	-	55,134	47,560	41,626	36,473	30,662
Construction In Progress	-	7,992	4,891	5,657	8,529	6,732

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error